The interferon sensitivity determining region in the era of combination therapies and the rational use of such therapies for patients with HCV genotype 1b infection.
Moriguchi
Hisashi
H
Chung
Raymond T
RT
Contreras
Ana Maria
AM
Izumi
Namiki
N
Uemura
Takamoto
T
Kobayashi
Makoto
M
Sato
Chifumi
C
D000998:Antiviral Agents / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
D000998:Antiviral Agents; D011994:Recombinant Proteins; D007372:Interferons